Scott Wilkie
- Oncology top 2%
- Molecular Biology
- Biomedical Engineering top 5%
- Immunology top 5%
- Genetics top 5%
- Co-authors
- John MaherDavid M. DaviesSjoukje J. C. van der StegenS. BurbridgeMay CI van SchalkwykStephen J. MatherJulie FosterCarol Box
- Topics
- CAR-T cell therapy research (10 papers)Monoclonal and Polyclonal Antibodies Research (8 papers)Antibiotics Pharmacokinetics and Efficacy (4 papers)
- Cited by
- OncologyImmunologyGenetics
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryThe Journal of Immunology
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Scott Wilkie
23 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 78
- Oncology 1.2k
- Molecular Biology 539
- Biomedical Engineering 502
- Immunology 475
- Genetics 368
Countries citing papers authored by Scott Wilkie
This map shows the geographic impact of Scott Wilkie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Wilkie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Wilkie more than expected).
Fields of papers citing papers by Scott Wilkie
This network shows the impact of papers produced by Scott Wilkie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Wilkie. The network helps show where Scott Wilkie may publish in the future.
Co-authorship network of co-authors of Scott Wilkie
This figure shows the co-authorship network connecting the top 25 collaborators of Scott Wilkie. A scholar is included among the top collaborators of Scott Wilkie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Wilkie. Scott Wilkie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 199 | |
| 5 | 5 | |
| 6 | 100 | |
| 7 | 95 | |
| 8 | 399 | |
| 9 | 87 | |
| 10 | 157 | |
| 11 | 273 | |
| 12 | Dosing regimen and hematologic effects of pentoxifylline and its active metabolites in normal dogs. | 8 |
| 13 | 3 | |
| 14 | 41 | |
| 15 | Time course of enrofloxacin and its active metabolite in peripheral leukocytes of dogs. | 13 |
| 16 | Pharmacokinetics of the bovine formulation of enrofloxacin (Baytril 100) in horses. | 10 |
| 17 | Tissue concentrations of enrofloxacin and ciprofloxacin in anesthetized dogs following single intravenous administration. | 13 |
| 18 | 73 | |
| 19 | 27 | |
| 20 | 7 |
About Scott Wilkie
Scott Wilkie is a scholar working on Oncology, Molecular Medicine and Radiology, Nuclear Medicine and Imaging, having authored 25 papers that have together received 1.6k indexed citations. Recurring topics across this work include CAR-T cell therapy research (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). The work is most often cited by research in Oncology (1.2k citations), Immunology (475 citations) and Genetics (368 citations). Scott Wilkie has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include John Maher, David M. Davies, Sjoukje J. C. van der Stegen, S. Burbridge, May CI van Schalkwyk, Stephen J. Mather, Julie Foster, Carol Box, Suzanne A. Eccles and Steve Hobbs. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.